about
Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobioticsMetabolite parameters as an appropriate alternative approach for assessment of bioequivalence of two verapamil formulationsThe risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockersSelective opening of mitochondrial ATP-sensitive potassium channels during surgically induced myocardial ischemia decreases necrosis and apoptosisEffects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedureIssues in drug metabolism of major antihypertensive drugs: beta-blockers, calcium channel antagonists and angiotensin receptor blockers.Therapy of acute hypertension in hospitalized children and adolescents.An angiotensin-converting enzyme (ACE) polymorphism may mitigate the effects of angiotensin-pathway medications on posttraumatic stress symptoms.Spectroscopic and HPLC studies of photodegradation of nilvadipine.The association between nitroglycerin use and adverse outcomes in women undergoing cesarean delivery in the second stage of labor.Drugs and Scaffold That Inhibit Cytochrome P450 27A1 In Vitro and In Vivo.
P2860
Q26849557-3EE1F2D8-502D-4F00-8585-6D698DD38B29Q34146073-E743276A-622F-4363-82E7-64853E959FFDQ34589838-E64A491F-49C9-4C94-A16A-7A70B9845442Q37011696-C38C1772-5283-480A-AD24-4BB4F294F52FQ37138222-0E4AC9C2-7885-455E-8216-59171089416DQ37679899-5DB163F9-9357-4D0C-83CC-61869B476CFEQ38187598-6065A354-169F-4EB2-AB34-BD24A854A68BQ39013181-4FCB4A07-FC2D-4496-A263-6C0FB1A26588Q43856893-D30B969C-934B-4EA3-B75C-4D30B34E662CQ46732265-27D6BE44-C8C0-42F0-BA22-7FCBE0482F57Q47941602-3A34AEDD-451B-441E-8735-DE0381126E16
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Clinical pharmacokinetics of vasodilators. Part I.
@en
Clinical pharmacokinetics of vasodilators. Part I.
@nl
type
label
Clinical pharmacokinetics of vasodilators. Part I.
@en
Clinical pharmacokinetics of vasodilators. Part I.
@nl
prefLabel
Clinical pharmacokinetics of vasodilators. Part I.
@en
Clinical pharmacokinetics of vasodilators. Part I.
@nl
P2093
P1476
Clinical pharmacokinetics of vasodilators. Part I.
@en
P2093
P304
P356
10.2165/00003088-199834060-00003
P577
1998-06-01T00:00:00Z
P6179
1030947514